CytoDyn (CYDY)
OTHER OTC:CYDY

CytoDyn (CYDY) Financial Statements

591 Followers

CytoDyn Financial Overview

CytoDyn's market cap is currently ―. The company's EPS TTM is $-0.266; its P/E ratio is -1.26; CytoDyn is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 22Aug 22May 22Feb 22Nov 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 225.00K
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 173.00K
EBIT$ -24.76M$ -19.27M$ -70.85M$ -29.55M$ -29.68M
EBITDA$ -24.70M$ -19.17M$ -70.73M$ -29.42M$ -29.43M
Net Income Common Stockholders$ -28.00M$ -25.53M$ -112.06M$ -32.33M$ -36.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.40M$ 4.68M$ 4.23M$ 1.36M$ 8.88M
Total Assets$ 7.07M$ 28.39M$ 29.18M$ 94.08M$ 103.70M
Total Debt$ 37.28M$ 37.22M$ 36.80M$ 36.24M$ 44.58M
Net Debt$ 34.88M$ 32.54M$ 32.57M$ 34.87M$ 35.71M
Total Liabilities$ 123.04M$ 122.71M$ 123.58M$ 116.54M$ 116.39M
Stockholders Equity$ -115.97M$ -94.31M$ -94.40M$ -22.46M$ -12.70M
Cash Flow-
Free Cash Flow$ -4.41M$ -11.07M$ -6.01M$ -11.06M$ -28.90M
Operating Cash Flow$ -4.41M$ -11.07M$ -6.04M$ -11.05M$ -28.89M
Investing Cash Flow$ 0.00$ 0.00$ 30.00K$ -17.00K$ -5.00K
Financing Cash Flow$ 2.33M$ 11.52M$ 7.88M$ 4.55M$ 31.23M
Currency in USD

CytoDyn Earnings and Revenue History


CytoDyn Debt to Assets


CytoDyn Cash Flow


CytoDyn Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis